These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CEACAM5, CEA AND Clinical Outcome
60 results:

  • 1. Proinflammatory and cancer-Promoting Pathobiont
    Cavallucci V; Palucci I; Fidaleo M; Mercuri A; Masi L; Emoli V; Bianchetti G; Fiori ME; Bachrach G; Scaldaferri F; Maulucci G; Delogu G; Pani G
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139097
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable colorectal cancer Prognosis.
    Cui C; Zhang R; Gu F; Pei Y; Sun L; Huang Y; Niu G; Li J
    J Immunol Res; 2022; 2022():1336509. PubMed ID: 35664357
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer.
    Jia N; Chang L; Gao X; Shi X; Dou X; Guan M; Shao Y; Li N; Cheng Y; Ying H; Sun Z; Zhou Y; Zhao L; Zhou J; Bai C
    BMC Cancer; 2021 Jul; 21(1):845. PubMed ID: 34294055
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive factors of complete pathological response in patients with locally advanced rectal cancer.
    Engel RM; Oliva K; Koulis C; Yap R; McMurrick PJ
    Int J Colorectal Dis; 2020 Sep; 35(9):1759-1767. PubMed ID: 32474708
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
    Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients.
    Gabizon AA; Tahover E; Golan T; Geva R; Perets R; Amitay Y; Shmeeda H; Ohana P
    Invest New Drugs; 2020 Oct; 38(5):1411-1420. PubMed ID: 31955309
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and outcomes after the Resection of colorectal Liver Metastases.
    Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
    J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.
    Diefenhardt M; Hofheinz RD; Martin D; Beißbarth T; Arnold D; Hartmann A; von der Grün J; Grützmann R; Liersch T; Ströbel P; Grabenbauer GG; Rieger M; Fietkau R; Graeven U; Weitz J; Folprecht G; Ghadimi M; Rödel F; Rödel C; Fokas E;
    Int J Cancer; 2019 Oct; 145(8):2282-2291. PubMed ID: 30868576
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of ceacam5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
    Messaritakis I; Sfakianaki M; Papadaki C; Koulouridi A; Vardakis N; Koinis F; Hatzidaki D; Georgoulia N; Kladi A; Kotsakis A; Souglakos J; Georgoulias V
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):767-775. PubMed ID: 30094617
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon cancer.
    Fei B; Dai W; Zhao S
    Med Sci Monit; 2018 May; 24():3184-3192. PubMed ID: 29763415
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
    Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
    Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors.
    Carvalho TI; Novais PC; Lizarte FS; Sicchieri RD; Rosa MS; Carvalho CA; Tirapelli DP; Peria FM; Rocha JJ; Féres O
    Acta Cir Bras; 2017 Mar; 32(3):243-250. PubMed ID: 28403349
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression.
    Ye M; He Y; Lin H; Yang S; Zhou Y; Zhou L; Zhong J; Lu G; Zheng J; Xue ZX; Cai ZZ
    Oncol Rep; 2017 May; 37(5):2955-2963. PubMed ID: 28393252
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.
    Luo Y; Qin SL; Yu MH; Mu YF; Wang ZS; Zhong M
    Biomed Pharmacother; 2015 Dec; 76():147-52. PubMed ID: 26653562
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Survival in Resected Stage II colorectal cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative cea Level, and The Number of Examined Lymph Nodes.
    Tsai HL; Huang CW; Chen CW; Yeh YS; Ma CJ; Wang JY
    World J Surg; 2016 Apr; 40(4):1002-9. PubMed ID: 26560149
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Prognostic Value of Preoperative Serum cea and CA19-9 Values in Stage I-III colorectal cancer.
    Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
    Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cea/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
    Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
    MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cea change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 3.